Nationwide Recall Issued for Blood Pressure Medication Due to Dissolution Issues

Macleods Pharma USA has issued a Class II nationwide recall for specific lots of its generic triple-action blood pressure medication, Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets. The recall was initiated because the tablets failed dissolution tests, meaning they may not dissolve properly and could be ineffective. This could lead to a temporary reduction in blood pressure control, though the likelihood of serious health consequences is considered remote. Patients are advised to check their prescription bottles for affected lot numbers and consult their pharmacists or healthcare providers.